InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (7 ops.)
Discover the full record of transactions filed by Wilson Mark Andrew, Directeur Juridique. Insider active across 2 companies, notably NEKTAR THERAPEUTICS. Cumulatively, 11 filings have been recorded. Total volume traded: €185k. The latest transaction was filed on 16 May 2022 (Cession). Regulator: SEC (Form 4). All data is free.
Declarations11 total
€11,8663,136 shares@ €3.78390.0005% mcap6.4% of flow
Common Stock
SEC:0001209191-22-029904:0·
€35,2993,661 shares@ €9.64180.0015% mcap40.8% of flow
Common Stock
SEC:0001209191-22-011441·
€35,2993,661 shares@ €9.64180.0015% mcap19.1% of flow
Common Stock
SEC:0001209191-22-011441:0·
037,800 shares0
Common Stock
SEC:0001209191-21-070695·
037,800 shares0
Common Stock
SEC:0001209191-21-070695:0·
020,100 shares0
Common Stock
SEC:0001209191-21-065225·
020,100 shares0
Common Stock
SEC:0001209191-21-065225:0·
€22,4241,910 shares@ €11.74030.0009% mcap25.9% of flow
Common Stock
SEC:0001209191-21-052393·
€22,4241,910 shares@ €11.74030.0009% mcap12.1% of flow
Common Stock
SEC:0001209191-21-052393:0·
€28,8571,917 shares@ €15.05320.0012% mcap33.3% of flow
Common Stock
SEC:0001209191-21-034190·
€28,8571,917 shares@ €15.05320.0012% mcap15.6% of flow
Common Stock
SEC:0001209191-21-034190:0·
11 of 11 declarations
About Wilson Mark Andrew
Mark Andrew Wilson is the General Counsel and SVP at Nektar Therapeutics. He is responsible for managing the company's legal affairs and regulatory compliance. With a strong background in corporate law, Mark plays a key role in protecting the company's interests and managing legal risks. His expertise is essential for ensuring compliance with laws and regulations.
